Lung function and mortality in the United States: Data from the First National Health and Nutrition Examination Survey follow up study

Thorax

Volumn 58, Issue 5, 2003, Pages 388-393

  Mannino, D M ^a   Buist, A S ^b   Petty, T L ^c   Enright, P L ^d   Redd, S C ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c HealthOne   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; EDUCATION; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENDER; HAZARD ASSESSMENT; HEALTH SURVEY; HUMAN; LUNG FUNCTION; MORTALITY; PREDICTION; PRIORITY JOURNAL; RACE; SMOKING; SMOKING CESSATION; UNITED STATES;

ADULT; AGED; BODY MASS INDEX; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SURVIVAL RATE; UNITED STATES; VITAL CAPACITY;

EID: 0038752573     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.5.388     Document Type: Article

References (36)

1. Mannino DM, Homa DM, Akinbami L, et al. Surveillance for chronic obstructive pulmonary disease: United States, 1971-2000. MMWR CDC Surveillance Summaries 2002;50.
2. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77-121.
3. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHL81/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
4. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000;160:1683-9.
5. Postma DS, Sluiter HJ. Prognosis of chronic obstructive pulmonary disease: the Dutch experience. Am Rev Respir Dis 1989;140:S100-5.
6. Neas LM, Schwartz J. Pulmonary function levels as predictors of mortality in a national sample of US adults. Am J Epidemiol 1998;147:1011-8.
7. Anthonisen NR. Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials. Am Rev Respir Dis 1989;140:S95-9.
8. Hospers JJ, Postma DS, Rijcken B, et al. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000;356:1313-7.
9. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313:711-5.
10. Knuiman MW, James AL, Divitini ML, et al. Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol 1999;9:297-306.
11. Schunemann HJ, Dorn J, Grant BJ, et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000;118:656-64.
12. National Center for Health Statistics. Plan and operation of the HANES I augmentation survey of adults 25-74 years, United States, 1974-75. Washington, DC: National Center for Health Statistics, 1978.
13. National Center for Health Statistics. Plan and operation of the Health and Nutrition Examination Survey, United States, 1971-73. Washington, DC: National Center for Health Statistics, 1973.
14. Cohen BB, Barbano HE, Cox CS, et al. Plan and operation of the NHANES I Epidemiologic Followup Study: 1982-84. Vital Health Stat 1987;1:1-142.
15. Cox CS, Mussolino ME, Rothwell ST, et al. Plan and operation of the NHANES I Epidemiologic Followup Study, 1992. Vital Health Stat 1997;1:1-231.
16. Cox CS, Rothwell ST, Madans JH, et al. Plan and operation of the NHANES I Epidemiologic Followup Study, 1987. Vital Health Stat 1992;1:1-190.
17. Finucane FF, Freid VM, Madans JH, et al. Plan and operation of the NHANES I Epidemiologic Followup Study, 1986. Vital Health Stat 1990;1:1-154.
18. O'Brien RJ, Drizd TA. Basic data on spirometry in adults 25-74 years of age: United States, 1971-75. Vital Health Stat 1981;11:1-36.
19. American Thoracic Society. Standardization of spirometry - 1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987;136:1285-98.
20. Anon. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med 1998;158:1855-67.
21. Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987;317:1309-14.
22. Engstrom G, Hedblad B, Janzon L, et al. Respiratory decline in smokers and ex-smokers: an independent risk factor for cardiovascular disease and death. J Cardiovasc Risk 2000;7:267-72.
23. Ryan G, Knuiman MW, Divitini ML, et al. Decline in lung function and mortality: the Busselton Health Study. J Epidemiol Community Health 1999;53:230-4.
24. Bang KM, Gergen PJ, Kramer R, et al. The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest 1993;103:536-40.
25. Pelkonen M, Tukiainen H, Tervahauta M, et al. Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men. Thorax 2000;55:746-50.
26. Sharp DS, Masaki K, Burchfiel CM, et al. Prolonged QTc interval, impaired pulmonary function, and a very lean body mass jointly predict all-cause mortality in elderly men. Ann Epidemiol 1998;8:99-106.
27. Stewart AG, Waterhouse JC, Howard P. The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD. Respir Med 1995;89:79-84.
28. Volterrani M, Scalvini S, Mazzuero G, et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 1994;106:1432-7.
29. Maltais F, LeBlanc P, Jobin J, et al. Peripheral muscle dysfunction in chronic obstructive pulmonary disease. Clin Chest Med 2000;21:665-77.
30. Rahman I, MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 1996;51:348-50.
31. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 1997;156:341-57.
32. Camilli AE, Robbins DR, Lebowitz MD. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 1991;133:795-800.
33. Hunt LW Jr, Silverstein MD, Reed CE, et al. Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA 1993;269:1947-52.
34. American Thoracic Society. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis 1991;144:1202-18.
35. Aaron SD, Dales RE, Cardinal P. How accurate is spirometry at predicting restrictive pulmonary impairment? Chest 1999;115:869-73.
36. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000;117:1146-61.